Learn more at LeadIQ.com

Insights

Strategic Partnerships Sio Gene Therapies has a history of forming strategic partnerships with companies like Invitae Corporation, allowing for collaborative opportunities to expand genetic testing services. Sales professionals can leverage these partnerships to offer combined solutions to a wider range of clients and tap into new markets.

Product Diversification With a pipeline that includes gene therapies for rare pediatric conditions like GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, and expanding to prevalent conditions like Parkinson's disease, there's a wide range of products to offer potential customers. Sales representatives can tailor their pitches to address specific needs across different disease areas.

Key Personnel Changes The appointment of David Nassif as interim CEO presents an opportunity for sales teams to align their strategies with the new leadership's vision. Building relationships with key executives can lead to better understanding of business priorities and uncover new avenues for product promotion and sales growth.

Strategic Alliances Through partnerships with companies like Oxford Biomedica plc, Sio Gene Therapies has shown a commitment to collaboration for mutual success. Sales professionals can explore these alliances to create bundled offerings, access new resources, and position themselves advantageously in the market.

Clinical-stage Programs The launch of clinical-stage AAV gene therapy programs for GM1 and GM2 gangliosidosis presents a unique sales opportunity to engage with healthcare providers and institutions that focus on these specific rare diseases. By highlighting the potential impact of these therapies, sales teams can drive interest and adoption among target audiences.

Similar companies to Sio Gene Therapies

Sio Gene Therapies Tech Stack

Sio Gene Therapies uses 8 technology products and services including Akamai, web-vitals, Office 365, and more. Explore Sio Gene Therapies's tech stack below.

Akamai
Content Delivery Network
web-vitals
Javascript Libraries
Office 365
Office Suites
Microsoft Windows Server
Operating Systems
Acquia Cloud Platform
Platform As A Service
HSTS
Security
Akamai Web Application Protector
Security
Acquia Cloud Site Factory
Web Hosting

Media & News

Sio Gene Therapies's Email Address Formats

Sio Gene Therapies uses at least 2 format(s):

Sio Gene Therapies Email Formats	Example	Percentage
First.Last@axovant.com	John.Doe@axovant.com	98%
FirstMiddle.Last@axovant.com	JohnMichael.Doe@axovant.com	2%
First.Last@siogtx.com	John.Doe@siogtx.com	100%

Frequently Asked Questions

Where is Sio Gene Therapies's headquarters located?

Sio Gene Therapies's main headquarters is located at 11 Times Square New York, New York 10036 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Sio Gene Therapies's stock symbol?

Sio Gene Therapies is a publicly traded company; the company's stock symbol is SIOX.

What is Sio Gene Therapies's official website and social media links?

Sio Gene Therapies's official website is siogtx.com and has social profiles on LinkedIn.

What is Sio Gene Therapies's SIC code NAICS code?

Sio Gene Therapies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sio Gene Therapies have currently?

As of March 2022, Sio Gene Therapies has approximately 67 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Associate Director, Data Management: B. B.Associate Director Clinical Operations: A. B.Senior Director Clinical Operations: T. G.. Explore Sio Gene Therapies's employee directory with LeadIQ.

What industry does Sio Gene Therapies belong to?

Sio Gene Therapies operates in the Biotechnology Research industry.

What technology does Sio Gene Therapies use?

Sio Gene Therapies's tech stack includes Akamaiweb-vitalsOffice 365Microsoft Windows ServerAcquia Cloud PlatformHSTSAkamai Web Application ProtectorAcquia Cloud Site Factory.

What is Sio Gene Therapies's email format?

Sio Gene Therapies's email format typically follows the pattern of . Find more Sio Gene Therapies email formats with LeadIQ.

How much funding has Sio Gene Therapies raised to date?

As of March 2022, Sio Gene Therapies has raised $75M in funding. The last funding round occurred on Feb 19, 2020 for $75M.

When was Sio Gene Therapies founded?

Sio Gene Therapies was founded in 2014.

Sio Gene Therapies

Sio Gene Therapies

Biotechnology ResearchNew York, United States51-200 Employees

Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development experts, and supported by collaborations with premier academic, industry and patient advocacy organizations, Sio is focused on accelerating its candidates through clinical trials to liberate patients with debilitating diseases through the transformational power of gene therapies. 

For more information, visit www.siogtx.com.

Company Overview

Headquarters: 11 Times Square New York, New York 10036 US
Website: siogtx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: SIOX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2014
Employees: 51-200

Media & News

Funding & Financials

$75M
Sio Gene Therapies has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Feb 19, 2020 in the amount of $75M.

Funding & Financials

$75M
Sio Gene Therapies has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Feb 19, 2020 in the amount of $75M.

Company Leadership

B. B.
Associate Director, Data Management
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Associate Director Clinical Operations
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. G.
Senior Director Clinical Operations
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. C.
Manager, It Operations (consultant)
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. C.
Senior Procurement Manager
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

N. M.
Lab Manager/Research Assistant
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. J. W.
Senior Clinical Research Liaison
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. G. T.
Gene Therapy
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. K.
Scientist, Early Development
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
General Counsel
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sio Gene Therapies and Millions of Other Companies
Sign up for full access to Sio Gene Therapies information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.